Nuveen LLC Makes New Investment in Huron Consulting Group Inc. $HURN

Key Points

• Nuveen LLC acquired a new position in Huron Consulting Group Inc., purchasing 268,465 shares valued at approximately $38.51 million, representing about 1.56% of the company's stock.
• Huron Consulting Group reported $1.89 earnings per share for the latest quarter, exceeding analyst expectations, along with an 8.3% year-over-year revenue increase.
• Analysts currently rate Huron Consulting Group as a Moderate Buy with an average target price of $171.50, though one analyst downgraded the stock from a "buy" to a "hold".

Nuveen LLC bought a new position in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 268,465 shares of the business services provider's stock, valued at approximately $38,511,000. Nuveen LLC owned 1.56% of Huron Consulting Group at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Aigen Investment Management LP increased its position in Huron Consulting Group by 10.5% during the first quarter. Aigen Investment Management LP now owns 1,879 shares of the business services provider's stock worth $270,000 after acquiring an additional 178 shares during the period. Entropy Technologies LP bought a new position in Huron Consulting Group during the first quarter worth $463,000. Invesco Ltd. increased its position in Huron Consulting Group by 7.9% during the first quarter. Invesco Ltd. now owns 282,017 shares of the business services provider's stock worth $40,455,000 after acquiring an additional 20,680 shares during the period. Neumeier Poma Investment Counsel LLC increased its position in Huron Consulting Group by 0.7% during the first quarter. Neumeier Poma Investment Counsel LLC now owns 244,318 shares of the business services provider's stock worth $35,047,000 after acquiring an additional 1,760 shares during the period. Finally, Headlands Technologies LLC bought a new position in Huron Consulting Group during the first quarter worth $868,000. Institutional investors own 93.90% of the company's stock.

Insider Buying and Selling at Huron Consulting Group

In other news, Director H Eugene Lockhart sold 1,040 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $136.74, for a total value of $142,209.60. Following the sale, the director owned 8,162 shares of the company's stock, valued at approximately $1,116,071.88. This represents a 11.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director James H. Roth sold 2,000 shares of the company's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $128.98, for a total transaction of $257,960.00. Following the completion of the sale, the director directly owned 43,304 shares in the company, valued at approximately $5,585,349.92. The trade was a 4.41% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 4,711 shares of company stock worth $624,066. Corporate insiders own 2.15% of the company's stock.

Huron Consulting Group Stock Performance

Huron Consulting Group stock traded up $0.10 on Thursday, hitting $135.39. The company's stock had a trading volume of 99,541 shares, compared to its average volume of 196,494. The firm has a market cap of $2.34 billion, a P/E ratio of 23.63 and a beta of 0.26. The company has a quick ratio of 1.99, a current ratio of 1.99 and a debt-to-equity ratio of 1.35. The company has a fifty day moving average price of $133.59 and a 200-day moving average price of $138.81. Huron Consulting Group Inc. has a one year low of $102.58 and a one year high of $155.00.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The business services provider reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.10. The firm had revenue of $402.50 million for the quarter, compared to analyst estimates of $402.67 million. Huron Consulting Group had a net margin of 6.60% and a return on equity of 25.52%. The business's revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.68 EPS. Huron Consulting Group has set its FY 2025 guidance at 7.300-7.70 EPS. On average, equities analysts anticipate that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Analyst Ratings Changes

HURN has been the topic of a number of research reports. Wall Street Zen lowered shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Barrington Research boosted their target price on shares of Huron Consulting Group from $173.00 to $176.00 and gave the stock an "outperform" rating in a research report on Thursday, August 7th. Five analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $171.50.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.